PKTX (ProtoKinetix) Quality Rank

View and export this data going back to 2017. Start your Free Trial

What is ProtoKinetix Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

ProtoKinetix Quality Rank Related Terms

Thank you for viewing the detailed overview of ProtoKinetix's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

ProtoKinetix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProtoKinetix Inc (OTCPK:PKTX) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

109 W Main Street, Dalton, OH, USA, 44618

Website

https://www.protokinetix.com

ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.

Executives

Clarence Edward Smith	director, 10 percent owner, officer: President & CEO	1845 COUNTY ROAD #214, ST. AUGUSTINE FL 32084
Michael Richard Guzzetta	officer: CFO	412 MULBERRY STREET, MARIETTA OH 45750
Lachlan Grant Young	10 percent owner	6438 ROSEBERY AVE., WEST VANCOUVER A1 V7W2C6
Edward P. Mcdonough	director	1226 WASHINGTON AVENUE, PARKERSBURG WV 26101
Susan Marie Woodward	officer: CFO	705 DUGAN ROAD, BELPRE OH 45714
Peter Krogh Jensen	director	4656 HOSKINS ROAD, NORTH VANCOUVER A1 V7K 2R1
Ian Thomas Gregory	director	2225 FOLKESTONE WAY, WEST VANCOUVER A1 V7S 2Y6
Ross Laurence Senior	director, officer: CEO	PH-3, 5688 DALHOUISE ROAD, VANCOUVER A1 V6T 1W4
Mark L Baum	director, officer: President	C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130